Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere, officially launched May 9, 2023. Revvity, previously affiliated with PerkinElmer, Inc., and building on a legacy of innovation, represents all aspects that are part of the PROXIDRUGS consortium. Working together, we are excited to continue the collaboration and impact health worldwide.
